Furthermore, it provides an overview of the anti-obesity and anti-diabetic effects mediated by the enhanced endogenous secretion of GLP-1 and their underlying mechanisms. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.